|
|
Blood, 15 July 2004, Vol. 104, No. 2, pp. 336-339.
Prepublished online as a Blood First Edition Paper on March 30, 2004; DOI 10.1182/blood-2004-02-0636.
 Previous Article | Table of Contents | Next Article 
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Declining stroke rates in Californian children with sickle cell disease
Heather J. Fullerton,
Robert J. Adams,
Shoujun Zhao, and
S. Claiborne Johnston
From the Departments of Neurology, Pediatrics, and Epidemiology, University of California San Francisco; and the Department of Neurology, Medical College of Georgia, Augusta.
Although the Stroke Prevention Trial in Sickle Cell Anemia (STOP) demonstrated the efficacy of blood transfusions for primary stroke prevention in high-risk children with sickle cell disease (SCD) in 1998, the impact of this trial on public health has not been studied. Our objective was to determine whether stroke rates in Californian children with SCD have declined since 1998. Using a California-wide hospital discharge database, we identified all first admissions for stroke in children with SCD from 1991 through 2000. Annual stroke incidence rates were calculated as the number of admissions divided by the estimated population of Californian children with SCD in that year. For 1991-2000, 93 children with SCD were admitted to Californian hospitals with a first stroke during 12 030 person-years of follow-up; 92.5% were ischemic and 7.5% hemorrhagic. Overall, the rate of first stroke was 0.77/100 person-years. For the study years 1991-1998, the rate for first stroke was 0.88/100 person-years compared to 0.50 in 1999 and 0.17 in 2000 (P < .005 for trend). Since the publication of the STOP study in 1998, annual rates of admissions for first stroke for Californian children with SCD have declined. (Blood. 2004;104:336-339)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Childhood stroke frequency decreased in California during 1999 and 2000
- Darleen R. Powars
Blood 2004 104: 298-299.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
D. C. Rees, M. C. Dick, S. E. Height, S. O'Driscoll, K. R.E. Pohl, D. E. Goss, and C. R. Deane
A Simple Index Using Age, Hemoglobin, and Aspartate Transaminase Predicts Increased Intracerebral Blood Velocity as Measured by Transcranial Doppler Scanning in Children With Sickle Cell Anemia
Pediatrics,
June 1, 2008;
121(6):
e1628 - e1632.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation,
January 29, 2008;
117(4):
e25 - e146.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. T. Quinn, N. J. Lee, E. P. Shull, N. Ahmad, Z. R. Rogers, and G. R. Buchanan
Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort
Blood,
January 15, 2008;
111(2):
544 - 548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Mazumdar, M. M. Heeney, C. M. Sox, and T. A. Lieu
Preventing Stroke Among Children With Sickle Cell Anemia: An Analysis of Strategies That Involve Transcranial Doppler Testing and Chronic Transfusion
Pediatrics,
October 1, 2007;
120(4):
e1107 - e1116.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Adams
Hydroxyurea lowers TCD and also stroke?
Blood,
August 1, 2007;
110(3):
789 - 790.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Telfer, P. Coen, S. Chakravorty, O. Wilkey, J. Evans, H. Newell, B. Smalling, R. Amos, A. Stephens, D. Rogers, et al.
Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London
Haematologica,
July 1, 2007;
92(7):
905 - 912.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation,
February 6, 2007;
115(5):
e69 - e171.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. T. Lee, S. Piomelli, S. Granger, S. T. Miller, S. Harkness, D. J. Brambilla, R. J. Adams, and for the STOP Study Investigators
Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results
Blood,
August 1, 2006;
108(3):
847 - 852.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Smith, S. O. Oyeku, C. Homer, and B. Zuckerman
Sickle Cell Disease: A Question of Equity and Quality
Pediatrics,
May 1, 2006;
117(5):
1763 - 1770.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Thom, N. Haase, W. Rosamond, V. J. Howard, J. Rumsfeld, T. Manolio, Z.-J. Zheng, K. Flegal, C. O'Donnell, S. Kittner, et al.
Heart Disease and Stroke Statistics--2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation,
February 14, 2006;
113(6):
e85 - e151.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. S. Platt
Prevention and Management of Stroke in Sickle Cell Anemia
Hematology,
January 1, 2006;
2006(1):
54 - 57.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Villella
Declining Stroke Rates in Children with Sickle Cell Disease
AAP Grand Rounds,
January 1, 2005;
13(1):
1 - 2.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Col. K. C. Quirolo
Resources aid in management of sickle cell disease
AAP News,
October 1, 2004;
25(4):
190 - 191.
[Full Text]
[PDF]
|
|
|
| |
